Drug Information for Thiothixene Capsules, USP (Sandoz Inc.): REFERENCES

Ads
    • Worldwide Labeling Safety Report: Dyskinesia and Dyskinesia Tardive and Thiothixene, (16Apr02).
    • Worldwide Labeling Safety Report: Neuroleptic Malignant Syndrome and Thiothixene, (16Apr02).
    • Worldwide Labeling Safety Report: Hyperprolactinemia and Thiothixene, (16Apr02).
    • Ereshefsky L, Saklad SR, Watanabe MD, et al. Thiothixene Pharmacokinetic Interactions: A Study of Hepatic Enzyme Inducers, Clearance Inhibitors, and Demographic Variables. Journal of Clinical Psychopharmacology, 11(5):296-301, (1991).
    • Worldwide Labeling Safety Report: Drug Interaction and Thiothixene, (09May02).
    • McEvoy GK, Miller JL, Snow EK, et al. AHFS Drug Information. American Society of Health-System Pharmacists, Inc., p. 2334-2336, (2002).
    • Worldwide Labeling Safety Report: Menstrual Disorder and Thiothixene, (16Apr02).
  • Drug Information Provided by National Library of Medicine (NLM).
Ads